Latest Articles

Publication Date
Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options - The Daily Gazette

Endometriosis and fibroids: Expert explains advances giving women less invasive treatment options The Daily Gazette

Published: June 19, 2026, 8 a.m.
UCLA alumnus’s pioneering endometriosis treatment plans to enter clinical trials - Daily Bruin

UCLA alumnus’s pioneering endometriosis treatment plans to enter clinical trials Daily Bruin

Published: June 18, 2026, 4:55 p.m.
Cholesterol Accumulation Impairs Progestin Response in Fertility-Preserving Treatment of Endometrial Cancer and Atypical Hyperplasia - Vera Health

Cholesterol Accumulation Impairs Progestin Response in Fertility-Preserving Treatment of Endometrial Cancer and Atypical Hyperplasia Vera Health

Published: June 18, 2026, 12:22 p.m.
Off-Label Miracle: How Weight-Loss Drugs Transform Endometriosis Treatment - streamlinefeed.co.ke

Off-Label Miracle: How Weight-Loss Drugs Transform Endometriosis Treatment streamlinefeed.co.ke

Published: June 18, 2026, 9 a.m.
Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial - Vietnam Investment Review - VIR

Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial Vietnam Investment Review - VIR

Published: June 18, 2026, 8:05 a.m.
Adenomyosis is often mistaken for endometriosis, delaying diagnosis for years: Doctors explain diagnosis and treatment options - Gulf News

Adenomyosis is often mistaken for endometriosis, delaying diagnosis for years: Doctors explain diagnosis and treatment options Gulf News

Published: June 18, 2026, 2 a.m.
Bindi Irwin’s recovery and conservation commitment - MSN

Bindi Irwin’s recovery and conservation commitment MSN

Published: June 18, 2026, 1:47 a.m.
Data Updates Shift Treatment Standards in Gyn-Oncology - Medscape

Data Updates Shift Treatment Standards in Gyn-Oncology Medscape

Published: June 17, 2026, 1:18 p.m.
Vipoglanstat trial reaches recruitment halfway point - FemTech World

Vipoglanstat trial reaches recruitment halfway point FemTech World

Published: June 17, 2026, 11:04 a.m.
Antibody therapy points to a new treatment era for primary membranous nephropathy - Drug Discovery News

Antibody therapy points to a new treatment era for primary membranous nephropathy Drug Discovery News

Published: June 16, 2026, 9:19 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!